Literature DB >> 1641072

Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action.

E Spinedi1, R Hadid, T Daneva, R C Gaillard.   

Abstract

Antigen-activated immune cells acutely release cytokines which, besides their effects on the immune system, increase hypothalamopituitary-adrenocortical (HPA) function to counteract the inflammatory process. The present study was designed to test, using in vitro paradigms, whether there exists a hypothalamic and/or a median eminence site of action, whereby different substances derived from the immune system could stimulate the CRH and/or the arginine-vasopressin (AVP) neuronal pathway. For this purpose, whole medial basal hypothalamus (containing the median eminence) were dissected from female rats and incubated in vitro with several concentrations of interleukin-1 (IL-1)beta, interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, thymosin fraction 5 (TF5) or bacterial lipopolysaccharide (LPS). After a 40-min incubation period, the amounts of CRH and AVP released into the incubation medium were measured by specific radioimmunoassays (RIAs). Additional experiments were carried out by superfusing isolated rat median eminence fragments with the different test substances; CRH and AVP released into the medium were also measured by RIAs. The results indicated that IL-1 beta (10(-11) to 10(-7) M), IL-6 (0.06 x 10(-10) to 0.4 x 10(-10) M), TNF-alpha (6 x 10(-9) to 6 x 10(-7) M) and TF5 (5-500 micrograms/ml) but not LPS (1-100 ng/ml) significantly enhanced hypothalamic CRH secretion above baseline in a concentration-related fashion. Additionally, superfusion experiments demonstrated that, among all test substances, only IL-6 possesses a direct and dose-dependent CRH-releasing activity at the median eminence level. Conversely, no preparation enhanced basal AVP release in either in vitro design.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641072     DOI: 10.1159/000126207

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

2.  Sex difference in link between interleukin-6 and stress.

Authors:  Ryan Jankord; James R Turk; James C Schadt; Jennifer Casati; Venkataseshu K Ganjam; Elmer M Price; Duane H Keisler; M Harold Laughlin
Journal:  Endocrinology       Date:  2007-05-17       Impact factor: 4.736

3.  Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.

Authors:  I Shimon; X Yan; D W Ray; S Melmed
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 4.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

5.  Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice.

Authors:  J Raber; R D O'Shea; F E Bloom; I L Campbell
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

Review 6.  The organization of the stress system and its dysregulation in depressive illness.

Authors:  P W Gold
Journal:  Mol Psychiatry       Date:  2014-12-09       Impact factor: 15.992

7.  Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.

Authors:  C Scheid; R Young; R McDermott; L Fitzsimmons; J H Scarffe; P L Stern
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

8.  Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress.

Authors:  Milena Girotti; Jennifer J Donegan; David A Morilak
Journal:  Psychoneuroendocrinology       Date:  2012-12-04       Impact factor: 4.905

9.  The plasma interleukin-6 and stress hormone responses to acute pyelonephritis.

Authors:  R A Donald; R R Bailey; D Hart; J H Livesey; M J Evans; L Mattioli; J Macdonald; A H Smith
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

10.  Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease.

Authors:  Hershel Raff; Hariprasad Trivedi
Journal:  Endocr Connect       Date:  2012-11-19       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.